There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
Thousands have fled Burundi as violent protests against the president's decision to stand for a third term break out, leaving five dead.
Once a fringe party, the SNP has become a thundering political juggernaut that shows no sign of slowing down.
Turning cooler and more unsettled this week, as a low pressure system dominates our weather.